Business Advisory services                  Life Sciences Consulting                  Product Development                  ANDAs                  FTFs                  505 b 2 a                  Late Stage Assets                  Phase-II Trials                  Marketing Authorization’s                  Dossiers                  Site Transfers                  Scale ups                   Tail End Brands                  Technologies and Know-how                  Project Management                   Business Excellence & Six Sigma
A large multinational pharmaceutical company decided to more diligently manage the late life cycle products in its portfolio, and to divest such products at a point when sales had begun to decline and sales resources had been reassigned to other products.
This company had worked previouslywith Garphi, when the company had out-licensed a product to a client of Garphi. The company requested Garphi to manage the divestment project for them. Garphi prepared the Information Memorandums, identified appropriate targets, generated competition for the asset, assisted with buyers’ due diligence investigation, and finally the negotiation of the definitive agreement.
As a result of the controlled auction process utilized by Garphi, the company received a better deal for its assets. They have since retained Garphi to manage additional divestment assignments.